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Abstract
Background: MHC/HLA class II molecules are important components of the immune system and
play a critical role in processes such as phagocytosis. Understanding peptide recognition properties
of the hundreds of MHC class II alleles is essential to appreciate determinants of antigenicity and
ultimately to predict epitopes. While there are several methods for epitope prediction, each
differing in their success rates, there are no reports so far in the literature to systematically
characterize the binding sites at the structural level and infer recognition profiles from them.
Results: Here we report a new approach to compare the binding sites of MHC class II molecules
using their three dimensional structures. We use a specifically tuned version of our recent
algorithm, PocketMatch. We show that our methodology is useful for classification of MHC class II
molecules based on similarities or differences among their binding sites. A new module has been
used to define binding sites in MHC molecules. Comparison of binding sites of 103 MHC molecules,
both at the whole groove and individual sub-pocket levels has been carried out, and their clustering
patterns analyzed. While clusters largely agree with serotypic classification, deviations from it and
several new insights are obtained from our study. We also present how differences in sub-pockets
of molecules associated with a pair of autoimmune diseases, narcolepsy and rheumatoid arthritis,
were captured by PocketMatch13.
Conclusion: The systematic framework for understanding structural variations in MHC class II
molecules enables large scale comparison of binding grooves and sub-pockets, which is likely to
have direct implications towards predicting epitopes and understanding peptide binding
preferences.
Page 1 of 13
(page number not for citation purposes)
BioMed Central
Open Access
Background
Major histocompatibility complex (MHC) class II mole-
cules are important components of the immune system
and play a critical role in processes such as phagocytosis.
Antigenic peptide binding by these molecules is a pre-
requisite for triggering immune responses. The diversity
in antigen recognition is achieved through hundreds of
class II alleles labelled by their serotypes, each differing
from the others in terms of the residues at the binding
site and their precise three dimensional arrangement.
The nature of binding site of an MHC class II molecule
(Figure 1) has an important bearing on the immune
system of an individual [1,2]. MHC class II molecules
provide important clues in understanding autoimmune
diseases (e.g. [3-5]) and susceptibility to pathogens. In
the context of tuberculosis, it has been reported that
different MHC alleles bind peptides from Mycobacterium
tuberculosis with different specificities, influencing an
individual’s susceptibility to infection [6-8].
A thorough knowledge of the structure of the binding
site is useful in designing or identifying peptide antigens
for rational vaccine design. In addition, knowledge of
similar or dissimilar sites aid in understanding peptide
specificities. While a general appreciation of the differ-
ences between a pair of structures can be obtained
through interactive molecular graphics software tools, a
thorough characterization of the differences and their
mapping to individual residues in the corresponding
structures, and more importantly obtaining a quantita-
tive perspective of the extent of similarities, necessarily
requires a systematic method for their analysis.
We have recently reported a new algorithm PocketMatch [9]
based on alignment of sorted distance elements binned
into point-type-pair bins. An important step that precedes
pocket comparison is the definition of the binding site
itself. In the previous study, all residues (or any atoms in
them) that were present in a 4 Å zone around any atom of
the ligand were taken to constitute the site. This approach
though common, is rather simplistic and more detailed
methods to define the binding site need to be explored to
have more accurate site definitions. Here we incorporate a
new module for defining binding sites and apply it for a
large scale comparison of binding sites in the MHC class II
molecules.
The modified algorithm is referred to as PocketMatch13
hereafter. Further, we show that our algorithm is useful
for classification of MHC class II molecules based on
binding site analysis. The algorithm captures the overall
shape, detailed geometry and the chemistry at the binding
sites. This analysis also aids in understanding peptide
preferences by different alleles which may become the
first step in the optimal design of allele specific antigens.
Figure 1
Structure of an MHC class II binding groove. (A) Binding domain of HLA-DR1 [PDB:1DLH], with the five pockets in the
binding groove highlighted (P1 - red; P4 - yellow; P6 - green; P7 - blue; P9 - purple). Lines are drawn between the centres of
binding site atoms that can be touched simultaneously by a probe sphere. (B) The influenza virus peptide from [PDB:1DLH] is
shown above the binding groove, with peptide side chains shown in the same colour as the pockets into which they fit.
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Results and Discussion
We report a new approach for a large scale comparison
of binding sites in protein structures and apply it for
comparing and classifying a set of 103 MHC class II
molecules. The method, which utilizes structural features
of the whole site as well as of the sub-pockets, also serves
as a high resolution framework to systematically under-
stand similarities and differences among alleles. We have
used this to identify automatically intra- and inter-allelic
variations in the binding grooves of molecules in the
data set, and to explore the structural basis for correla-
tions with disease.
Inter-allelic variations
To investigate similarities across MHC molecules of
different types, one MHC molecule was selected from
each of the 65 Protein Data Bank (PDB) entries in the
dataset, and all-against-all comparisons were carried out
on this set of 65 molecules (Table 1). Binding site
similarity scores (PM13Scores ) were computed for all the
pairs of molecules both at the level of whole groove and
sub-pocket levels. Cladograms were generated to show
similarities and differences in PM13Scores across the
dataset, both at the level of the whole groove, and at the
level of the five sub-pockets (Figures 2 and Figures S1-S4
in Additional file 1). In addition to considering whole
binding groove, it is important to know how the
similarities of the sub-pockets (P1, P4, P6, P7, P9) vary
as these are the ones that determine peptide specificity.
Some MHC molecules of the same type are in different
branches of the cladogram calculated for the whole
groove, however clustering at the sub-pocket level was
more in line with the different MHC molecule types,
particularly for the P4 sub-pocket. This suggests that the
P4 sub-pocket is more structurally conserved within an
allele, but difference occurs across alleles. The impor-
tance of the P4 sub-pocket has been noted in many
studies (e.g. [1,2,10]).
Some different MHCmolecules are grouped together in the
same branch in some of the sub-pocket trees. In these cases,
the PM13Scores highlight similarities that would otherwise
be difficult to spot in a large dataset. These can be followed
up by looking for independent observations about these
similarities that have been reported in the literature. The
matching alleles, corresponding PDB codes and PM13Scores
for pairs of sub-pockets are listed in (Table 2), where the
significance of the grouping of different alleles is discussed
and supporting references are presented.
Table 1: Dataset used in this study. 103 MHC class II molecules from 65 PDB files were used. #Mol – Number of molecules; #PDB –
Number of PDB entries
Alleles Supertype [21] #PDB PDB Identifiers #Mol
DQA1*0102-DQB1*0602 DQ1 1 1UVQ 1
DQA1*0301/2/3-DQB1*0302 DQ8 2 1JK8, 2NNA 2
DQA1*0501/3/5/6/7/8/9-DQB1*0201/2 DQ2 1 1S9V 2
DRA*0101/2-DRB1*0101 DR1 22 1AQD, 1DLH, 1FYT, 1HXY, 1JWM, 1JWS, 1JWU,
1KG0, 1KLG, 1KLU, 1LO5, 1PYW, 1SEB, 1SJE, 1SJH,
1T5W, 1T5X, 2FSE, 2G9H, 2IAM, 2IAN, 2IPK
32
DRA*0101/2-DRB1*0301 DR3 1 1A6A 1
DRA*0101/2-DRB1*0401 DR4 2 1J8H, 2SEB 2
DRA*0101/2-DRB1*1501 DR2 3 1BX2, 1YMM, 2WBJ 5
DRA*0101/2-DRB3*0101 DR52 1 2Q6W 2
DRA*0101/2-DRB3*0301 DR52 1 3C5J 1
DRA*0101/2-DRB5*0101 DR51 4 1FV1, 1H15, 1HQR, 1ZGL 8
H2-Aa – 1 1ES0 1
H2-Aa, H2-Ab1 – 17 1D9K, 1F3J, 1IAK, 1IAO, 1JL4, 1K2D, 1LNU, 1MUJ,
1U3H, 2IAD, 2P24, 2PXY, 2Z31, 3C5Z, 3C60, 3C6L, 3CUP
26
H2-Ea – 2 1IEB, 1KTD 4
H2-Ea, H2-Eb1 – 7 1FNE, 1FNG, 1I3R, 1IEA, 1KT2, 1R5V, 1R5W 16
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Figure 2
Cladograms based on similarities between binding sites. The cladograms for the whole groove and the P4 sub-pocket
level similarities among alleles. The first four characters of the label are the PDB identifier for the structure of the MHC class II
molecule. The next group of three letters are the chain identifiers used for the alpha chain, beta chain and peptide,
respectively, in the original PDB file (there are only two letters in this group in cases where the peptide has been engineered to
be part of one of the MHC chains). The final part of the label indicates which alpha and beta alleles are present in the MHC
molecule. Branches associated with diseases are shown in brackets with disease label. Disease names are abbreviated as NL:
Narcolepsy, T1D:Type 1 Diabetes, RA:Rheumatoid Arthritis, CD: Coeliac Disease and PTB:Pulmanory tuberculosis. The suffix
‘+’ stands for positive association and ‘-’ for negative association of an allele with disease. (A) The cladogram for the whole
groove similarities. (B) The cladogram for the P4 similarities. Different branches are indicated by black diamonds to indicate net
clustering.
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Table 2: Summary of the analysis performed on cladograms for the whole groove and five sub-pockets. For a pair of different alleles,
the pair of molecules obtaining high PM13 Score on whole groove or sub-pocket comparison is presented. Literature citation for other
independent work supporting the observation is also provided wherever possible. The examples shown here refer to different alleles
that appear in the same branch of the clustergarm computed either by using the whole grooves or by their individual sub-pockets as
indicated in each row
Pair of alleles (PDB1, PDB2) Pocket PM13
Score
Comment
DQB1*0602-DQB1*0302 (1UVQ, 1JK8) whole 0.83 The involvement of the two alleles DQB1*0602 and DQB1*0302,
negatively and positively associated with Type 1 diabetes is reported by
Siebold and co-workers [22]
(1UVQ, 2NNA) 0.75
(1UVQ, 2NNA) P4 0.74
(1UVQ, 1JK8) P7 0.71
DQB1*0201, 2-DRB1*1501 (1S9V, 1BX2) P7 0.4
DQB1*0201, 2-DRB1*1501 (1S9V, 1BX2) P9 0.08
DRB1*0401-DRB1*0101 (2SEB, 2FSE) P9 0.61
(1J8H, 2IPK) 0.85 The study by Rosloniec and co-workers [13] indicate the association of
the two alleles are known to be associated with RA.
DRB1*1501-DRB1*0101 (2WBJ, 1LO5) P9 0.69 These observations agree with the study by Smith and co-workers [23]
that reports the similarity of the P9 sub-pocket. Study by Drouin and
co-workers [24] refer to the association of the two alleles with
antibiotic-refractory arthritis.
(1YMM, 1KLU) 0.59
(1YMM, 2IAM) 0.66
DRB1*1501-DRB1*0301 (1BX2, 1A6A) whole 0.80 Both alleles came in two branches under a common root which is in
accordance with a study by Zivadinov and co-workers [25] that
associates the two alleles to Multiple sclerosis.
DRB3*0101-DRB1*0101 (2Q6W, 1HXY) P1 0.66
DRB3*0101-DRB1*0301 (2Q6W, 1A6A) P4 0.54 The two molecules are grouped together. Though the score is only
0.54, there are no other molecules they could come similar to with
matching allele types. The study by Parry and co-workers [26] indicate
the expected similarity in the P4 sub-pocket and correlate the
differences in other subpockets and the differences in P4 itself to
difference between the two alleles in susceptibility to Type 1 diabetes.
DRB3*0301-DRB1*0401 (3C5J, 1J8H) P6 0.43
(3C5J, 2SEB) 0.37
(3C5J, 2SEB) P7 0.77
DRB5*0101-DRB1*0101 (1HQR, 1PYW) whole 0.78
(1HQR, 2G9H) P1 0.9 Meinl and co-workers [27] also report similarity between the two allele
types in recognition of myelin basic protein. The P1 similarity between
the two alleles is reported by Jurcevic and co-workers [28].
(1H15, 1DLH) whole 0.8
(1H15, 1LO5) P1 0.73
(1ZGL, 1JWM) P1 0.8
DRB5*0101-DRB1*0301 (1FV1, 1A6A) P1 0.81 Though P1 score is high, the other subpocket scores are low (less than
0.34) which is in accordance with study by Texier and co-workers [29]
that reports difference between the two alleles in their peptide binding
properties.
P9 0.56
(1FV1, 1R5W) P9 0.6
(2Q6W, 3C5J) P9 0.84 This similarity of P9 is a known feature [30] for the two, DR52a and
DR52c alleles which are encoded by the DR3 gene whose alleles are all
associated with autoimmune diseases.
DQB1*0602-H2-Aa, H2-Ab1 (1UVQ, 1IAK) P6 0.64 Orthologous alleles from human and mouse [31].
(1UVQ, 1JL4) P9 0.71
(1UVQ, 2IAD) P9 0.75
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To analyze the net distribution of similarity scores with
respect to each other for each of the five sub-pockets, a
histogram is plotted for various bins of PM13Scores
(Figure 3). Each bin corresponds to a range of
PM13Scores. For example, bin-5 corresponds to a
PM13Score range of [0.5 to 0.6); bin-7 to the range [0.7
to 0.8) and so on. The histogram shows that P1 and P9
score highly at bin 6, corresponding to [0.6 to 0.7) of
PM13Score. The histogram gives an indication of the
overall distribution of scores for each sub-pocket viewed
in the context of others. This could possibly mean over-
representation of data or true conservation of these two
sub-pockets.
This analysis has implications for understanding subtle
differences that otherwise go undetected and aid in
understanding antigen recognition preferences by differ-
ent alleles and range of antigens recognized by a given
allele.
Intra-allelic variations
Some MHC molecules are present more than once in the
PDB entries in the dataset (Table 1). In these cases,
PocketMatch13 can be used to highlight differences in the
peptide binding sites in different structures for the same
allele.
The sites are first compared by considering the whole
binding grooves. In many cases, as expected, PM13Scores
are high, indicating strong similarities in the binding
sites of a given allele. However, there are cases where
PM13Scores are low for different structures of the same
molecule, for example different structures of DR1 and
DR5 give similarity scores as low as 0.44 (Table S1 in
Additional file 1). These differences can be explored by
examining the individual sub-pockets within the binding
grooves (see Methods). While many pairs of correspond-
ing sub-pockets score highly, indicating similarity in the
structures of the sub-pockets, in some cases the scores are
significantly lower. This can be due to differences in
MHC side chain conformations giving rise to different
sets of intra-site distances, or can be due to determina-
tion of which MHC atoms are accessible to a probe
sphere and are thus included in sub-pocket calculations.
Sub-pockets highlighted by PocketMatch13 to be
Table 2: Summary of the analysis performed on cladograms for the whole groove and five sub-pockets. For a pair of different alleles,
the pair of molecules obtaining high PM13 Score on whole groove or sub-pocket comparison is presented. Literature citation for other
independent work supporting the observation is also provided wherever possible. The examples shown here refer to different alleles
that appear in the same branch of the clustergarm computed either by using the whole grooves or by their individual sub-pockets as
indicated in each row (Continued)
DQB1*0201-H2-Aa, H2-Ab1 (1S9V, 2PXY) whole 0.73
(1S9V, 2Z31) 0.79
(1S9V, 3CUP) 0.78
(1S9V, 1MUJ) P1 0.57
DRB1*0101-H2-Aa, H2-Ab1 (1AQD, 1K2D) P1 0.52
(1D9K, 1SJE) P9 0.46
(1D9K, 1SJH) P9 0.53
DRB1*0301-H2-Aa, H2-Ab1 (1A6A, 1LNU) whole 0.83
(1A6A, 1IAO) 0.83
DRB1*1501-H2-Aa, H2-Ab1 (2WBJ, 1IAO) P7 0.42
(2WBJ, 1LNU) 0.57
DRB1*1501-H2-Ea, H2-Eb1 (1R5V, 1BX2) P6 0.65 Orthologous alleles from human and mouse.
Figure 3
Frequencies of PM13Scores (labelled PMScore) for the
five sub-pockets and whole binding groove. X-axis: 10
bins of PM13Scores ranging from 0 to 1.0. Red, yellow, green,
blue and purple bars correspond to the P1, P4, P6, P7 and P9
sub-pockets. Black bars correspond to whole groove
similarity scores.
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dissimilar can then be examined in detail to identify the
reason for the low PM13Scores. Some examples of sub-
pockets with low PM13 Scores are illustrated in Figure 4.
A pair of molecules belonging to DR1 exhibited low scores
[PDB:1AQD, PDB:1DLH] in their P1 sub-pockets. Upon
careful examination, we noticed that the P1 sub-pocket in
1DLH was wider and deeper with many more MHC atoms
being included in the PocketMatch13 definition of the P1
sub-pocket. Considering the set of DRA*0101-
DRB1*1501 structures, the largest difference is between
the P7 pockets of [PDB:1BX2] and [PDB:2WBJ] (Figure
4A). The peptide residue at the P7 position is oriented very
differently in these two structures – in [PDB:1BX2], an
isoleucine is oriented away from the groove, whereas in
[PDB:2WBJ] a leucine is oriented “across” the top of the
groove. Since the P7 peptide residue in [PDB:2WBJ]
obstructs the P7 sub-pocket more than the P7 peptide
residue in [PDB:1BX2], this affects the set of MHC atoms
that are selected for the sub-pocket comparison calcula-
tion, and thus reduces the PM13Score (0.06).
The two independent molecules in the crystal structure
of DQ8 [PDB:1S9V] differ from each other at the P9 sub-
pocket (Figure 4B); the difference between the two
molecules at the P9 position is noted by [11]. This
analysis indicates that PocketMatch13 is sufficiently
sensitive to capture subtle differences that exist among
molecules belonging to the same allele.
Correlation with disease: case studies
Several MHC class II alleles are known to be either
positively or negatively associated with certain diseases,
and this motivates studies to identify the reasons for
disease susceptibility in terms of three-dimensional
molecular structure [1]. For example, Jones et al. [1]
review the structures of alleles that are known to be
positively or negatively associated with various diseases,
including narcolepsy and rheumatoid arthritis (RA). We
have used PocketMatch13 to examine the binding grooves
of alleles discussed by Jones et al. [1] in connection with
narcolepsy and RA, using experimentally determined
structures from the PDB where these are available, and
model structures when they are not (see Methods). In case
of Narcolepsy, the pockets of the binding groove in the
experimentally determined structure of HLA-DQ6.2
(positively associated with the disease) [PDB:1UVQ],
Figure 4
Examples of sub-pockets with low PM13 Scores. (A) Detail of the superposed binding grooves of [PDB:1BX2] (red) and
[PDB:2WBJ] (green). MHC and peptide main chains are represented by a cartoon trace. Spheres indicate the centres of MHC
atoms that are determined to be part of the binding groove (see Methods). The centres of MHC atoms that are determined to
be part of the P7 sub-pocket are represented by the larger spheres; these atoms are labelled in blue. The Ca and Cb atoms of
the peptide residues at the P7 positions, remodelled as alanines, are shown with a ball-and-stick representation. (B) Similar to
(A), but focusing on the P9 sub-pockets in [PDB:1S9V] (chains A, B, C in red; chains D, E, F in green).
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were compared to those in a model structure of
HLA-DQ6.1 (negatively associated with the disease).
These molecules differ at only a few positions in the
b chain. PocketMatch13 identified the P4 sub-pocket
corresponding to the Thr6 residue of the peptide to be the
most dissimilar between these two structures (Table 3). The
residues Ala13bb and Tyr26b in HLA-DQ6.2 changed to
Gly13b and Leu26b in HLA-DQ6.1 in the neighbourhood
of peptide residue Thr6, corresponding to P4 (Figure 5A);
this difference is captured by the PocketMatch13 algorithm.
In case of RA, alleles HLA-DR4.1, HLA-DR4.4 and HLA-
DR1 are positively associated with the disease, while
HLA-DR4.2 is neutral or negative [1]. The a chains of
these four MHC molecules are the same (DRA*0101),
and sequence comparison of the b chains with ClustalW
[12] gives sequence identities of – DR4.1:DR4.2 = 95%,
DR4.1:DR4.4 = 97%, DR4.1:DR1 = 88%, DR4.2:DR4.4 =
96%, DR4.2:DR1 = 85%, DR4.4:DR1 = 88%. Given that
the whole sequence similarities are not sensitive enough
to capture differences at the binding site levels, we use
PocketMatch13 to compare the binding grooves and sub-
pockets of the experimentally determined structures of
HLA-DR4.1 [PDB:1J8H] and HLA-DR1 [PDB:1DLH], and
model structures of HLA-DR4.2 and HLA-DR4.4.
PocketMatch13 gives low scores for the P4 sub-pocket
(Table 4A). It has been shown by Hammer and co-
workers [10] that the difference in residues 70 and 71 in
the b chain of the DR4.1 and DR4.2 MHCs accounts for
the difference in binding specificity of the peptides.
Figure 5
Detail of the binding grooves of HLA-DQ6.2 and HLA-DR4.2. (A) Detail of the binding groove of HLA-DQ6.2 (green).
MHC and peptide main chains are represented by a cartoon trace. Spheres indicate the centres of MHC atoms that are
determined to be part of the binding groove (see Methods). The centres of MHC atoms that are determined to be part of the
P4 sub-pocket are represented by the larger spheres; these atoms are labelled in blue. The Ca and Cb atoms of the peptide
residue at the P7 position, remodelled as alanine, is shown with a ball-and-stick representation. Atoms that differ in binding
groove of the model structure of HLA-DQ6.1 are shown in red. (B) Detail of the binding groove of HLA-DR4.2 (red). MHC
and peptide main chains are represented by a cartoon trace. Spheres indicate the centres of MHC atoms that are determined
to be part of the binding groove (see Methods). Atoms that differ in binding groove of the model structure of HLA-DR4.1 are
shown in green. The centres of atoms of residues 70b and 71b are represented by the larger spheres; these atoms are labelled
in blue. The Ca and Cb atoms of the glutamine residue at the P4 position in the peptide are shown with a ball-and-stick
representation (yellow).
Table 3: Similarity scores between sub-pockets of HLA-DQ6.1
and HLA-DQ6.2. PMSMax and PMSMin are defined in Methods
Peptide residue Pocket PMSMin PMSMax
Leu3 P1 1.0 1.0
Thr6 P4 0.57 0.84
Val8 P6 0.90 0.90
Ser9 P7 1.0 1.0
Ala11 P9 0.92 0.92
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The low P4 scores are in line with that study. The
superposition of these two alleles is shown in Figure 5B.
The P4 peptide residue has Gln70b and Lys71b present
in HLA-DR4.1 within 3.0 Å of the residue whereas an Asp
at the position 70b and only Glu71b are present in the
case of the model built for HLA-DR4.2.
All-against-all PM13Scores are presented in Table 4B, C.
The scores indicate low PM13Score of [PDB:1DLH] to
others in the P7 region of the binding site. Work by
Rosloniec and co-workers found that mutation of the
residue at the P7 position to an alanine has affected T
cell stimulation more with DR4 than with DR1 [13]. The
involvement of P7 sub-pocket in peptide recognition
specificity is also discussed in [10]. In carrying out these
case studies, model structures have been a useful
supplement to the set of experimentally determined
MHC class II molecules. We envisage future studies that
make use of larger sets of model structures where the
binding grooves have been modelled consistently using
the same protocol [14].
Conclusion
A strategy for automatically comparing MHC class II
binding grooves and sub-pockets based on their chemi-
cal nature and geometry is presented. Comparisons are
facilitated by a pre-processing step in which MHC-
peptide complexes are extracted from PDB files, and
chains and structurally equivalent residue positions are
relabelled consistently. Pocket similarity scores calcu-
lated by PocketMatch13 can be used as the basis for
clustering pockets based on their structural and chemical
characteristics.
The framework we report can be used to carry out large
scale comparison of binding grooves and sub-pockets,
both to highlight differences in the binding grooves of
MHC molecules of the same kind, and to identify
similarities in the binding grooves of different MHC
alleles. Investigations of MHC alleles associated with
narcolepsy and rheumatoid arthritis demonstrate that
binding grooves of alleles that are positively associated
with an autoimmune disease can be compared with
Table 4: Sub-pocket similarities. (A) Sub-pocket similarities between a pair of alleles HLA-DR4.1 [PDB:1J8H] and HLA-DR4.2 (model)
are shown. The residues of the peptide are shown on the left most column. Residue numbers 311 and 314 correspond to P4 and P7
respectively. The low PM13Scores are shown in boldface. (B) Variation of the P4 similarity scores among HLA-DRB1*0101
[PDB:1DLH], HLA-DR4.1 [PDB:1J8H], HLA-DR4.4 and HLA-DR4.2 are shown. (C) Variation in P7 similarities are shown for proteins
mentioned under (B)
(A) - HLA-DR4.1(1J8H-abc) and HLA-DR4.2(model)
Pocket Residue PMSMin PMSMax
P1 Tyr308 0.85 0.91
P4 Gln311 0.79 0.85
P6 Thr313 0.89 0.89
P7 Leu314 0.53 0.71
P9 Leu316 1.0 1.0
(B) - P4 (Gln311)-similarity
PDB/MODEL PDB/MODEL PMSMin PMSMax
1DLH 1J8H 0.56 0.60
1DLH HLA-DR4.2 0.53 0.53
1DLH HLA-DR4.4 0.63 0.68
1J8H HLA-DR4.2 0.79 0.85
1J8H HLA-DR4.4 0.86 0.86
HLA-DR4.2 HLA-DR4.4 0.74 0.79
(C) - P7 (Leu314)-similarity
PDB/MODEL PDB/MODEL PMSMin PMSMax
1DLH 1J8H 0.44 0.58
1DLH HLA-DR4.2 0.50 0.50
1DLH HLA-DR4.4 0.67 0.67
1J8H HLA-DR4.2 0.53 0.71
1J8H HLA-DR4.4 0.60 0.81
HLA-DR4.2 HLA-DR4.4 0.57 0.57
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those that are known to be negatively associated with the
disease. The structural variations among binding pockets
identified by PocketMatch13 corroborate known disease
associations. Future applications of this systematic
framework for understanding structural variations in
MHC class II molecules could have direct implications
towards predicting epitopes and understanding peptide
binding preferences.
Methods
Dataset preparation
103 MHC class II molecules from 65 Protein Data Bank
[15] entries are used in this study (Table 1), and the
sequences of the a1 and b1 domains from these
structures were matched with allele sequences from
IMGT/HLA database [16] to confirm which allele is
present in the PDB entry. In this study, the focus is on
MHC class II binding domains. In some cases, different
alleles share identical sequences for the binding region,
e.g. human alpha chains DRA*0101 and DRA*0102
have binding domains with identical sequences, so both
of these alleles are listed alongside structures with this
alpha chain sequence in Table 1. Similarly, many alleles
have binding domains with sequences that are identical
to those in [PDB:1S9V], and these are listed in Table 1.
To facilitate automatic comparison of MHC class II
structures, uniform chain identifiers and residue num-
bers were used for all MHC-peptide complexes extracted
from the PDB files. New files were written where each file
contains the core parts of an a1 domain, a b1 and a
peptide, with chains relabelled to match the chain
identifiers A, B and C in [PDB:1DLH], and residues
renumbered to match the numbering of residues at
structurally equivalent positions in [PDB:1DLH]. Posi-
tions 5-78 of the a1 domain and positions 5-91 of the b1
domain were retained. A rigid body transformation was
applied to superpose the the MHC binding domain
complexes onto chains A and B of [PDB:1DLH<http://
www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1DLH>], so
that all complexes are in the same frame of reference.
This transformation is not necessary for the automatic
comparisons that follow, but it is convenient for
comparing structures using molecular graphics to review
results from the automatic comparisons. Peptide resi-
dues corresponding to the 13 peptide residues in
[PDB:1DLH] were identified by structural comparison,
and peptide residues beyond the 13-residue peptide
present in [PDB:1DLH] were removed automatically.
Comparative modelling
To enable the comparison of binding grooves of MHC
class II molecules known to be positively or negatively
associated with narcolepsy or RA, models of HLA-DQ6.1
consisting of alleles (HLA-DQA1*0102 and HLA-
DQB1*0601), HLA-DRB4.2 (alleles HLA-DRA1*0101
and HLA-DRB1*0402) and HLA-DRB4.4 (alleles HLA-
DRA1*0101 and HLA-DRB1*0404) were built interac-
tively using the Swiss-PdbViewer [17]. [PDB:1UVQ] was
used as the template structure for the model of HLA-
DQ6.1 and [PDB:1J8H] was used as the template for
HLA-DRB4.2 and HLA-DRB4.4.
Binding site comparison
Binding sites are represented in a frame invariant manner
by distances between pairs of points, partitioned into
bins, and pairs of sites are compared based on alignment
of sorted sequences of distances. The sorted arrays are
then aligned and scored to finally obtain comparison
scores.
Molecules can be clustered based on their comparison
scores.
In this study, the points used are the centres of those
atoms lining the binding site. These are determined by
considering accessibility to a probe sphere with radius
1.4 Å. Those MHC atoms whose accessibility is reduced
by the presence of the peptide are determined to be part
of the peptide binding site. Similarly, the MHC atoms
that comprise individual pockets are identified as the set
of atoms whose accessibility is reduced by the presence
of the peptide residue at position P1, P4, P6, P7 or P9.
The ProtOr radii from Table 2 of [18] are used for
protein atomic groups in accessibility calculations.
The corresponding pockets between a pair of MHC
binding sites are compared on large scale in an all-
against-all comparison scheme. The shape signature of
each pocket, capturing chemical nature and geometric
distribution of atoms, is derived based on the distance
lists concept used in PocketMatch [9].
Site comparison proceeds as follows:
• Surface atomic groups are classified into 13 types
based on heavy-atom types, the number of covalently
attached hydrogen atoms and the number of all
covalently attached atoms, as proposed by Tsai et al.
[18]: C3H0, C3H1, C4H1, C4H2, C4H3, N3H0,
N3H1, N3H2, N4H3, O1H0, O2H1, S2H0, S2H1.
• Distances between all pairs of atoms are computed
and binned into 13 * (13 - 1)/2 + 13 Æ 91 lists
corresponding to each pair of atomic types (C3H0-
C3H0, C3H0-C3H1, etc.)
• Each list or bin of distances is then sorted in non-
decreasing order. The sorted distance elements
binned into various lists according to chemical
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nature of the atoms constitutes the shape descriptor
of the binding pocket.
• To compare a pair of sites, each of the 91 lists is
chosen in one site together with the corresponding
list from the other site, and the cumulative number
of similar distance elements is determined.
• A pair of distances from two lists is marked a match
if the distance differ at most by a threshold of 0.5.
We call the tuned version of PocketMatch for the MHC
class II binding site comparison, by considering solvent
accessible atoms and 13 atomic group types, Pocket-
Match13.
The numerator is simply the number of matching intra-
site distances. However, the denominator can be the
number of intra-site distances in either the smaller site or
in the larger site – these give rise to two PM13Score values,
referred to as PMSMax and PMSMin, respectively. Unless
stated otherwise, PM13Score refers to the PMSMin value.
PM13Score values decrease as the similarity between a pair
of binding grooves decreases (Figure 6). The rate at which
the scores decrease is affected by the threshold chosen for
site comparison, since this affects the number of matching
distance elements between a pair of distance-sequences.
To illustrate the effect of perturbing the conformation of a
binding groove, the coordinates of atoms in the binding
groove of [PDB:1JWS] (A, B, C chains) were perturbed
randomly, and an ensemble of 1000 structures was
generated with root mean square deviation (RMSD)
values up to 5 Å with respect to the original [PDB:1JWS]
structure. We have used a similar strategy for sensitivity
analysis for the original PocketMatch algorithm [9] and
found that a threshold of 0.5 Å was adequate to
distinguish between similar and dissimilar sites. Figure 6A
shows the PM13Scores obtained by comparing the original
[PDB:1JWS] structure with each of the perturbed
structures in the ensemble. Rather than perturbing the
atomic coordinates randomly, an alternative method for
generating an ensemble of perturbed conformations
would be to use conformations from a molecular
dynamics trajectory. To investigate the effect of altering
the chemical nature of the binding groove while
retaining its original geometry, the atomic group labels
of some of the atomic groups in the binding groove of
[PDB:1JWS] (A, B, C chains) were re-assigned randomly,
and PocketMatch13 was used to compare the modified
binding groove with the original one (Figure 6B).
Figures 6A and 6B demonstrate that PM13Scores capture
differences due to both the geometry and the chemical
nature of the binding groove.
Figure 6
Effect of altering the geometry or chemistry of the binding groove on PM13Scores. Altered binding grooves are
compared with the original using PocketMatch13. PM13Scores calculated with different distance element alignment thresholds
are shown in different colours (1.0 Å in purple; 0.75 Å in cyan; 0.5 Å in red; 0.25 Å in green; 0.125 Å in blue). (A) The
coordinates of atoms in the binding groove of [PDB:1JWS] (A, B, C chains) were perturbed randomly, and an ensemble of
1000 structures was generated with RMSD values up to 5 Å with respect to the original [PDB:1JWS] structure. (B) The atomic
group labels of some of the atomic groups in the binding groove of [PDB:1JWS] (A, B, C chains) were re-assigned randomly.
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Cladogram generation
Given a set of binding sites (whole groove or sub-
pockets), one way of visualizing the relationships among
these is to generate a cladogram based on distances
between pairs of sites. The distance between a pair of
sites is defined here to be 1-PM13Score between the two
sites. The cladogram generation program is based on the
neighbour joining method available in Phylip-3.67 [19]
which generates trees in Newick format, which can be
visualized and labelled using MEGA [20]. When gen-
erating cladograms, data were input to the program in
descending order of PM13Scores.
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